SoundHound AI Inc vs Zimmer Biomet Holdings Inc — how do they compare? SoundHound AI Inc trades at $7.4 (market cap $3.29B), while Zimmer Biomet Holdings Inc trades at $97.03 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 5.6× SoundHound AI Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.
| SOUN | ZBH | |
|---|---|---|
Market Cap | $3.29B | $18.55B |
Sector | Technology | Health |
52-Week High | $21.40 | $107.71 |
52-Week Low | $5.70 | $79.58 |
Enterprise Value | $3.09B | $25.61B |
Dividend Yield | — | 0.99% |
Signals from Pluang's Aura AI — not financial advice
SoundHound AI (SOUN) trades at $7.40, down 0.8% on the day, with strong technical momentum indicated by bullish moving averages. The company shows impressive revenue growth of 45% in Q2 2026 and has beaten earnings expectations for three consecutive quarters. Recent news highlights the proposed LivePerson acquisition and the successful launch of the OASYS platform, which is accelerating enterprise adoption and driving improved guidance.
While growth prospects appear promising with 75% analyst buy ratings and an $8.50 consensus target, significant risks remain including persistent negative margins (-67.45% net income margin), high valuation multiples (P/S 15.31), and substantial cash burn. The stock offers growth potential but requires careful risk management given the premium valuation and path to profitability challenges.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Trailing returns across standard periods
Latest headlines on both assets
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →